ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER

Clinical trials for ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER explained in plain language.

Never miss a new study

Get alerted when new ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER trials appear

Sign up with your email to follow new studies for ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New depression pill shows promise in early trial

Symptom relief Completed

This study tested a new drug called CLE-100 in 146 adults with major depressive disorder who were already taking standard antidepressants. The goal was to see if adding CLE-100 could further reduce depression symptoms. Participants were randomly assigned to receive either CLE-100…

Matched conditions: ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER

Phase: PHASE2 • Sponsor: Clexio Biosciences Ltd. • Aim: Symptom relief

Last updated Apr 30, 2026 15:51 UTC

ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER

Get alerted when new ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER trials appear

New depression pill shows promise in early trial